Intelligent Bio Solutions Inc. INBS
1.70
(0.01)
(0.58%)
as of 25 Sep
- Market cap
- $5.7M
- P/E
- 0.0×
Follow INBS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(231.78%) | (149.66%) | (169.60%) | (306.76%) | |
| (99.85%) | (85.77%) | (95.01%) | (123.13%) | ||
ROIC |
(387.48%) | (69.74%) | (387.05%) | (606.86%) | |
Return on Tangible Assets |
3,551.01% | (153.26%) | (213.05%) | (504.77%) | |
Average Days of Receivables |
182.05 | 1,074.54 | 137.10 | 143.34 | |
Free Cash Flow per Share |
(11.86) | (10.21) | (7.06) | (8.30) | |
Free Cash Flow |
(10.14) | (9.71) | (11.26) | (12.22) | |
Capital Expenditures |
— | (0.33) | (0.31) | (0.29) | |
Piotroski F-Score |
3.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(199.27%) | (80.65%) | (70.16%) | (128.48%) | |
Accounts Receivable Turnover |
2.30 | 0.64 | 3.11 | 2.82 | |
Accounts Payable Turnover |
0.64 | 0.72 | 0.83 | 0.50 | |
Inventory Turnover |
2.74 | 2.98 | 3.22 | 4.11 | |
Average Days of Payables |
777.73 | 807.42 | 642.88 | 696.28 | |
Days of Inventory on Hand |
122.37 | 111.83 | 105.65 | 70.57 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
58.75% | 55.37% | 64.50% | 79.98% | |
Selling, General and Administrative Expense of Revenue |
292.50% | 288.52% | 264.81% | 249.15% | |
Share Based Compensation of Revenue |
1.46% | 2.77% | 2.85% | 4.63% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.93 | 0.83 | 0.94 | 0.96 | |
Depreciation/Fixed assets |
4.51 | 3.68 | 3.77 | 3.95 | |
Capex/Depreciation |
0.00 | (0.28) | (0.26) | (0.25) | |
Revenue per Share |
3.85 | 3.70 | 2.42 | 2.86 | |
Operating CF per Share |
(11.86) | (9.86) | (6.87) | (8.10) | |
Capex per Share |
0.00 | (0.35) | (0.19) | (0.20) | |
Capex to Sales |
0.00 | 0.09 | 0.08 | 0.07 | |
Net Profit Margin |
(330.08%) | (320.82%) | (301.47%) | (294.91%) |
Columns are period end dates